Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jabez Bioscience, Inc

Clinical trials sponsored by Jabez Bioscience, Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug JBZ-001 enters first human trial for Hard-to-Treat cancers Results expected Feb 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New drug JBZ-001 enters first human trial for Hard-to-Treat cancers

Disease control Recruiting now

This early-stage trial is testing a new oral drug called JBZ-001 in 25 adults with advanced solid tumors or certain blood cancers (like lymphoma) that have not responded to standard treatments. The drug works by blocking a protein cancer cells need to grow. The main goals are to …

Phase 1 • Sponsor: Jabez Bioscience, Inc • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC